Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease.
about
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and CancerBiomarkers for colitis-associated colorectal cancerFunctional comparison between genes dysregulated in ulcerative colitis and colorectal carcinoma.Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.Wine consumption and intestinal redox homeostasisCellular senescence and the senescent secretory phenotype: therapeutic opportunities.Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.Reduced intestinal tumorigenesis in APCmin mice lacking melanin-concentrating hormone.Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancerInflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitisUlcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation.Activation of mesenchymal stem cells by macrophages prompts human gastric cancer growth through NF-κB pathway.Tumor resistance.Translating advances from the basic biology of aging into clinical applicationIbuprofen inhibits colitis-induced overexpression of tumor-related Rac1bSurvival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family RegistryATG4B/autophagin-1 regulates intestinal homeostasis and protects mice from experimental colitis.Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.Molecular mechanisms underlying chronic inflammation-associated cancers.Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer.Therapeutic targeting of tumor-stroma interactions.New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin.TNF-α signaling in Fanconi anemia.Direct measurements of human colon crypt stem cell niche genetic fidelity: the role of chance in non-darwinian mutation selection.Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?Anti-inflammatory and antioxidative effects of Camellia oleifera Abel components.The methanol-ethyl acetate partitioned fraction from Chinese olive fruits inhibits cancer cell proliferation and tumor growth by promoting apoptosis through the suppression of the NF-κB signaling pathway.Translating the Science of Aging into Therapeutic Interventions.Tumor Necrosis Factor-Alpha Up-Regulates ICAM-1 Expression and Release in Intestinal Myofibroblasts by Redox-Dependent and -Independent Mechanisms.Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.Modulation of nuclear factor E2-related factor-2 (Nrf2) activation by the stress response gene immediate early response-3 (IER3) in colonic epithelial cells: a novel mechanism of cellular adaption to inflammatory stressInflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection.Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity.Recurrence and survival rates of inflammatory bowel disease-associated colorectal cancer following postoperative chemotherapy: a comparative study.The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.Transcriptional analysis of left-sided colitis, pancolitis, and ulcerative colitis-associated dysplasia.Large chromosome deletions, duplications, and gene conversion events accumulate with age in normal human colon crypts.Colonic Lamina Propria Inflammatory Cells from Patients with IBD Induce the Nuclear Factor-E2 Related Factor-2 Thereby Leading to Greater Proteasome Activity and Apoptosis Protection in Human Colonocytes.
P2860
Q26782065-0554D44C-917E-4C59-B846-AB64BBC14B3AQ28076165-FD6ABA6C-3DEA-4944-951E-F10FE4390484Q31132086-0E849432-45FB-47BB-BDAF-09A29E998C2CQ33707944-45CFE732-3055-4EF1-95F5-0F53BDAEAF41Q33857878-EEC60797-57FD-4A10-A17E-D6F49075E187Q34035882-99152387-CF23-4B75-A641-ADD709B9D288Q34039324-DEB4573C-4A0C-4113-99E2-6CCE451D451CQ34359222-E54A4D8D-9D1A-4FBF-B336-742C4EE3D3C4Q34393297-CF364AEB-D638-473E-BB16-132A782AACE7Q34662592-48AE4CEA-38C5-4103-AD0A-01053CDAD6C5Q34802663-E0120CA5-1358-4516-BEEA-00119DF9E946Q35168143-61EEF169-0F58-4E68-B7BE-BFF1D1E44E94Q36456492-7030380D-D851-45F1-A0FF-B629138542EFQ36528628-8F63EAEC-E678-4410-86E9-0041386E2FDDQ36567588-2BFC89A5-AD38-4F8F-A12C-F292D2AA81CEQ36897912-1AD2F020-01EA-4C46-BAE4-330FACA8893FQ37107133-9D432111-D2A0-445E-985E-D2A5AB129012Q37367984-A3EA2D47-072F-45C4-B78A-DE77D4A30722Q37376262-69402BB2-936F-46B8-80B1-0A2A88D0AE5AQ37605343-A97416A5-87C1-42EA-A0C1-75CAFECFAF80Q37610120-A3FE7970-156E-4C59-B322-3CF75546CF34Q37731507-E505EB65-CA89-4BD3-AC30-39F93A3AAE33Q37851151-BFD5FDFC-AEB8-49D8-AC32-8983DBCAAEA6Q37900677-7D5E2D30-188A-41AB-9943-875D0328F052Q38124483-78050CE0-8633-4293-9BFE-3693EF0A9D74Q38153397-9CF5D5AB-F201-4BA7-9AA6-EDE3768F794FQ38172801-818B4D41-23C0-4D46-B348-47E39DD7B465Q38644797-63846048-9CF5-4FB2-9964-E2F3DBD745EDQ38729872-221B94E4-B78A-475B-8724-169614C1B2C2Q38756902-42B26AB0-B889-4980-A607-744CEDE2591EQ38852709-B62C6094-DA2F-4D3A-AE8D-61B2DB88F8ABQ38879552-E9176E6E-9EA3-4938-A23F-C21CF728173CQ39047635-94BD13B9-92BC-4FBA-8719-C58EC3D1FBE1Q39242497-8725D85B-5EFD-4BB0-BD1E-D0F7AE01F25FQ39541011-CE8A3578-FCAD-4E23-A0B6-BD8E9E556C44Q39697807-E97BFC4B-241F-49C5-8494-2ACFB121638FQ41500559-CBC1209D-1E47-4CC4-B276-FF478152FFD9Q44682175-1FC4A268-418B-4366-8C11-9C80191BA286Q46129242-C601BCAE-426B-44D6-98F6-5FD247B4C790Q46476904-9AF1EA7A-ABD9-4684-91F3-D03967421BB7
P2860
Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms by which inflammati ...... in inflammatory bowel disease.
@en
Mechanisms by which inflammati ...... in inflammatory bowel disease.
@nl
type
label
Mechanisms by which inflammati ...... in inflammatory bowel disease.
@en
Mechanisms by which inflammati ...... in inflammatory bowel disease.
@nl
prefLabel
Mechanisms by which inflammati ...... in inflammatory bowel disease.
@en
Mechanisms by which inflammati ...... in inflammatory bowel disease.
@nl
P2093
P2860
P356
P1476
Mechanisms by which inflammati ...... in inflammatory bowel disease.
@en
P2093
Andre G Buret
Pamela M O'Connor
Paul L Beck
Tamia K Lapointe
P2860
P304
P356
10.1002/IBD.21217
P577
2010-08-01T00:00:00Z